Chairman of Kangyuan Pharmaceutical introduced.

Comrade Xiao Wei, doctor, researcher of traditional Chinese medicine, doctoral supervisor of Beijing University of Traditional Chinese Medicine, doctoral supervisor of Nanjing University of Traditional Chinese Medicine, distinguished professor of Anhui College of Traditional Chinese Medicine, visiting professor of Qingdao Ocean University, and the first batch of young and middle-aged scientific and technological leaders in Jiangsu Province, has successively won honorary titles such as Jiangsu Model Worker, Jiangsu Excellent Entrepreneur, Jiangsu Top Ten Outstanding Patent Inventors, and Jiangsu Innovative and Entrepreneurial Talents, and enjoys special allowances from the State Council. Currently, he is the chairman of Jiangsu Kangyuan Pharmaceutical Co., Ltd., the director of the State Key Laboratory of Chinese Medicine Pharmaceutical Technology, the representative of the 11th National People's Congress, the member of the Standing Committee of Lianyungang Municipal People's Congress, the alternate member of Lianyungang Municipal Committee, the member of the National Pharmacopoeia Committee, and the member of the state administration of traditional chinese medicine Traditional Chinese Medicine Standardization Expert and Technical Committee.

Comrade Xiao Wei has been engaged in the research and development of modern Chinese medicine for a long time, constantly using new technologies, new dosage forms and new excipients in modern drug research to enhance and enrich the technical connotation of Chinese medicine. He led the R&D team to carry out more than 70 new drug research and obtained 47 new drug certificates. Apply for 180 domestic and foreign invention patents, authorize 89 domestic invention patents and authorize 10 foreign invention patents; It has undertaken 24 scientific research projects at or above the provincial level, including the ninth five-year plan, the eleventh five-year plan, the major new drug creation project of the Ministry of Science and Technology, the "973 Plan" and other 13 key projects. Accumulated 36 papers and 3 monographs; The research and development project of new Chinese medicine he presided over won many national and provincial and ministerial awards, among which Jinzhen Oral Liquid won the second prize of scientific and technological progress in 2000 by the State Economic and Trade Commission, and five projects including Guizhi Fuling Capsule, Tianshu Capsule, Reduning Injection and Tongan Injection won the first prize of provincial scientific and technological progress. Five products, including Yuanhu Zhitong Soft Capsule, were rated as national new products; Guizhi Fuling Capsule, a new national drug developed by Guizhi Fuling Capsule, has developed into the first choice for treating gynecological blood stasis in China after years of market cultivation. It has passed the FDA IND review and is in the second phase of clinical research in the United States. 20 1 1 The project "Establishment and Application of Control System of Traditional Chinese Medicine Injection" led by Xiao Wei won the first prize of Jiangsu Science and Technology Progress.